Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy.

Typeset version

 

TY  - JOUR
  - Haider I, Cahill M.
  - 2004
  - October
  - Hematology
  - Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy.
  - Published
  - ()
  - 9
  - 5-6
  - 409
  - 411
DA  - 2004/10
ER  - 
@article{V348865,
   = {Haider I,  Cahill M. },
   = {2004},
   = {October},
   = {Hematology},
   = {Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy.},
   = {Published},
   = {()},
   = {9},
   = {5-6},
  pages = {409--411},
  source = {IRIS}
}
AUTHORSHaider I, Cahill M.
YEAR2004
MONTHOctober
JOURNAL_CODEHematology
TITLEFatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy.
STATUSPublished
TIMES_CITED()
SEARCH_KEYWORD
VOLUME9
ISSUE5-6
START_PAGE409
END_PAGE411
ABSTRACT
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URL
DOI_LINK
FUNDING_BODY
GRANT_DETAILS